The cells of living organisms in contact with the external environment are constantly attacked by different kinds of substances such as micro-organisms, toxins, and pollutants. With evolution, defense mechanisms, such as the secretion of mucus has been developed. Mucins are the main components of mucus. They are synthesized and secreted by specialized cells of the epithelium and in some case, by non mucin-secreting cells. Little was known about the structure of mucins until a decade ago. This is principally due to heavy glycosylation of mucins, which complicated their analysis. With the application of molecular biological methods, structures of the mucin core peptides (apomucins) are beginning to be elucidated. A total of eleven human mucin (MUC) genes have been identified and numbered in chronological order of their description: MUC5AC, MUC5B,. Of these, the complete cDNA sequence are published only for six mucins MUC1, MUC2, MUC4, MUC5B, MUC5AC, and MUC7. Human mucin genes, in general, show three common features: I) a nucleotide tandem repeat domain; II) a predicted peptide domain containing a high percentage of serines and threonines; III) complex RNA expression. The tandem repeats in mucins make up the majority of the backbone. Related to their structure, mucins can be classified in three distinct subfamilies: gel-forming, soluble, and membrane-bound. Each member from one family possesses common characteristics and probably specific functions. For a long time, they were thought to have the unique function of protecting and lubricating the epithelial surfaces. The study of the mucins structure as well as the relationship between structure and function show that mucins also possess other important functions, such as growth, direct implication in the fetal development, the epithelial renewal and differentiation, the epithelial integrity, carcinogenesis, and metastasis. This review presents the actual knowledge on the mucins
ABSTRACT
The cells of living organisms in contact with the external environment are constantly attacked by different kinds of substances such as micro-organisms, toxins, and pollutants. With evolution, defense mechanisms, such as the secretion of mucus has been developed. Mucins are the main components of mucus. They are synthesized and secreted by specialized cells of the epithelium and in some case, by non mucin-secreting cells. Little was known about the structure of mucins until a decade ago. This is principally due to heavy glycosylation of mucins, which complicated their analysis. With the application of molecular biological methods, structures of the mucin core peptides (apomucins) are beginning to be elucidated. A total of eleven human mucin (MUC) genes have been identified and numbered in chronological order of their description: MUC1-4, MUC5AC, MUC5B, MUC6-8, and MUC11-12. Of these, the complete cDNA sequence are published only for six mucins MUC1, MUC2, MUC4, MUC5B, MUC5AC, and MUC7. Human mucin genes, in general, show three common features: I) a nucleotide tandem repeat domain; II) a predicted peptide domain containing a high percentage of serines and threonines; III) complex RNA expression. The tandem repeats in mucins make up the majority of the backbone. Related to their structure, mucins can be classified in three distinct subfamilies: gel-forming, soluble, and membrane-bound. Each member from one family possesses common characteristics and probably specific functions. For a long time, they were thought to have the unique function of protecting and lubricating the epithelial surfaces. The study of the mucins structure as well as the relationship between structure and function show that mucins also possess other important functions, such as growth, direct implication in the fetal development, the epithelial renewal and differentiation, the epithelial integrity, carcinogenesis, and metastasis. This review presents the actual knowledge on the mucins Figure 1 . Schematic representation of the deduced amino acid sequences from the mucin genes MUC2, MUC5B, MUC5AC, and MUC6 localized on the chromosome 11 in p15.5. The domains D1, D2, D3, D', D4, B, C, and CK (cystin knot) show a high level of similarity with the respective domains of the pre pro-von Willebrand factor. The T/S/P domains are the domains rich in serine, threonine, and proline amino acid residues. Cys are domains rich in cystein amino acid residues, and PS is the peptide signal.
structure and the best-characterized function related to their structure.
INTRODUCTION
Mucins are O-glycoproteins with a high molecular weight and are produced by secretory epithelial cells for the lubrication and protection of ducts and lumen. Historically, purified mucin has been identified by its amino and carbohydrate composition that consists of a high percentage of serine, threonine, proline, alanine, glycine, and a large proportion of O-linked oligosaccharides (up to 80% of the total mass). The definition of mucins was unclear for a long period. Several families of proteins, membrane-bound or secreted by distinct cellular types with adhesion properties in common, were also called mucins. Thus, some authors make the epithelial mucins out from the leucocytes mucins and the endothelial mucins (1) .
The epithelial mucins share a number of common points, primarily in their coding sequence, with repetitions organized in tandem that code for peptides very rich in serine, threonine, and proline residues. The repetitive domain, which contains many putative O-glycosylation sites, for all mucins is in the central position. For the mucins whose genomic organizations are known, this domain is encoded by a unique exon. The size of this exon varies from 2.2 kb for MUC7 (2) to 21 kb for MUC4 (3) .
When the repetitive domain is longer than several kilobases, it is characterized by an inter-individual VNTR (variable number of tandem repeats) polymorphism. The VNTR polymorphism is caused by the instability of the number of repetitions from generation to generation (4) (5) (6) (7) . This VNTR polymorphism can be detected at the genomic level, the protein level (8) and the RNA level (9) . Southern blot techniques also reveal the presence of a mutational polymorphism for the repetitive domain of the mucin genes (4, 5, 7, 10) .
A second typical feature of mucins is the presentation in Northern blots of a polydisperse signal from low to very high molecular weight (11) (12) (13) (14) (15) (16) . The polydisperse pattern has been considered an original and inherent feature of mucins, and for a long period was unexplained. However, it has been demonstrated that mucin mRNAs are not polydisperse but rather very large (9) , among the largest reported for eukaryotes. Debailleul et al showed that the polydisperse signals observed for mucin mRNAs are inherent to degradation, and the preparation of mucin RNAs without extraction artifacts require an improved method to analyze large mRNAs (9) .
Because of their complex structure, mucins are difficult to study by classical biochemical procedures. With the application of recombinant technology, structures of the mucin core peptides (called apomucins) are being elucidated. Eleven human mucin (MUC) genes have been identified and designated as MUC1-4, MUC5AC MUC5B, MUC6-8 and MUC11-12 (2, 12, 14, (16) (17) (18) (19) (20) (21) (22) (23) . Based on recently deduced amino acid sequences, mucins are now categorized in three distinct families: gel forming (MUC2, MUC5AC, MUC5B and MUC6), soluble (MUC7), and membrane-bound (MUC1, MUC3, MUC4 and MUC12). MUC8 and MUC11 remain unclassified on this review.
HUMAN MUCIN GENES

Gel forming mucins
The gel forming family of mucins is composed of MUC2, MUC5AC, MUC5B, and MUC6. Their genes are clustered in a complex of 400 kb very rich in CpG islands on chromosome 11 in region p15.5 (24) . The cluster is localized between HRAS and IGF2. The deduced amino acid sequences of these genes are organized in domains with similar structural schemes. They exhibit in their distal part a high level of similarity with the pro-von Willebrand factor ( Figure 1) (25,26) . The four genes are organized in a complex in which the distribution of the restriction sites (24) with a great deal of symmetry and repetition seems to demonstrate the existence of many events of duplication. Computational and phylogenetic analyses have permitted the development of an evolutionary history of the four human mucin genes from an ancestor gene common to the human von Willebrand factor gene (27,28).
MUC2
MUC2 was first identified and described by Gum et al in 1989 (13) . The three first cDNA clones isolated, SMUC40, 41, and 42, have been cloned after the screening of a small intestine cDNA library with antisera prepared against the deglycosylated protein backbone of human colon cancer xenograft mucin. The three clones are composed of sequences repeated in tandem with a repetition unit of 69 bp. The full-length cDNA sequence ( Figure 1) , with its largest allele measuring 15,720 bp was characterized after a new cDNA library screening with these probes and RACE-PCR (Rapid Amplification of cDNA Ends-polymerase chain reaction) procedures (18,29).
The central domain of MUC2 is composed of two highly repetitive sequences. The first, in the central position, is characterized by the perfect repetition of one motif of 23 amino acids. This domain shows in Southern blot a VNTR polymorphism with the number of repetitions varying from 51 to 115 (6) . The second, located upstream, is composed of an irregular sequence repeated in tandem with a unit of 347 amino acids. These two sequences are rich in amino acid residues of serine, threonine, and proline. Study of mucins isolated from nude mouse xenografts of the LS174T colonic adenocarcinoma cell line by gel filtration and CsCl density gradient centrifugation showed that 78 % of the threonine residues are Oglycosylated. MUC2 may possess up to 1,000 oligosaccharidic chains (30). Two sequences rich in cysteine residues flank the N-terminal domain made up of the repeat of 347 residues. These domains are called Cys domains. MUC2 also possesses five D domains, so called because of their homology with the D domains of the von Willebrand factor. The D1, D2, D', and D3 domains are localized in its N-terminal part, whereas the D4 domain is localized in the C-terminal position. Downstream of the D4 domain, three other sequences show similarity with domains of the von Willebrand factor, one domain C, one domain B, and one domain CK (Cystin Knot). The CK domain is also found in other secreted proteins (31) such as the NDP (Norries Disease Protein). Sequence pattern searches and three-dimensional modeling suggest that the CK domain of the NDP has a tertiary structure similar to that of the transforming growth factor beta (TGFbeta) (32).
The initiation point for MUC2 gene transcription lies within a 7000-base GC-rich region. Like many genes exhibiting tissue-specific expression, it contains the TATA element located 25 bases from its initiation (33). Computer analysis revealed the presence of a CACCC motif between bases -91 and -73. This CACCC box appears to be important for MUC2 gene transcription. Sp1 is the most abundant binding factor for this motif. In addition, this element seems able to bind other factors. Likely candidates for additional factors that are able to bind this element include Sp2, Sp3, and Sp4. These are zinc-finger proteins with sequence similarity to Sp1 (34,35). Two other regions have also been identified as important for the expression of the MUC2 gene; one localized between bases -228 and -171 that may confer cell-type specificity, and the second a nuclear factor-kappaB site located between bases -1452 and -1441 that participates in the induction of MUC2 by Pseudomonas (34,36). Elements required for small intestine specific expression are also located between bases -2864 and +17 of the MUC2 5' flanking sequence (37).
MUC5B
A human tracheobronchial lambda gt 11 cDNA library was screened using an antiserum prepared against the deglycosylated protein backbone of human tracheobronchial mucins. Two cDNAs, designated JER28 and JER57, were obtained (12) . These clones consisted of an imperfect repetition of one unit of 87 bp. Using these probes, a full-length cDNA of 16986 bp has been isolated and characterized (Figure 1) (38-43) . The repetitive domain of MUC5B encodes a large exon in the central position. cell differentiation. In the first intron, a high number of GC boxes, Sp1 binding sites and CACCC are present. The central part of the intron is clustered by CACCC boxes, followed by an array of eight GA repeated in tandem containing the consensus sequence GGGGAGGGGCT, each separated by 8 to 10 bp. Other putative sites for the transcription factors have been shown such as three Sp1 binding sites, two activator protein (AP)-2 sites, one NFkapaB, one GATA-1 and one Adh-1 site. Sp1 site showed direct involvement in the regulation of MUC5B, in the promoter sequence as well as in the intron 1. Moreover, another factor, called NF1-MUC5B nuclear factor, has already been demonstrated to bind into the intron 1 (45).
MUC5AC
The structural organization of MUC5AC is now completely known (Fgure 1). Two clones, JER47 and JER58, were isolated, in parallel with the work on MUC5B, by screening of a human tracheobronchial lambda gt 11 cDNA library using antiserum prepared against the deglycosylated protein backbone of human tracheobronchial mucins (46) . These clones are composed of a sequence repeated in tandem of 24 bp, flanked in the case of JER47 by a sequence of 330 bp that codes for domains rich in cysteine amino acid residues. These Cys domains are similar to those of MUC2 and MUC5B. The clone NP3a was isolated from a human nasal polyp cDNA library using two unique nucleotide probes for human tracheobronchial mucin glycoprotein (TBM) generated via PCR with degenerate primers deduced from the TBM:TR-3A tryptic peptide sequence (47) . The clone L31 was isolated from an HT29-MTX (methotrexate) expression library using a polyclonal serum specific for normal gastric mucosa (48) . The two clones code for the C-terminus extremity of MUC5AC. They possess the domains similar to those of the von Willebrand factor D4, C, B, and CK. The isolation and characterization of a genomic cosmid clone, designated ELO9, spanning the 3'-region of MUC5AC and the 5'-region of MUC5B, shows that MUC5AC and MUC5B have the same transcriptional orientation. Moreover, comparative molecular analysis of the entire sequence of the 3'-region from MUC5AC and MUC5B points to a remarkable similarity in the size and the distribution of exons (18), and in the type of splice sites (49) . An oligonucleotide based on the sequence isolated by successive CsCl-gradient ultracentrifugation in the presence of guanidinium hydrochloride from human gastric mucin was used to screen a human stomach lambda ZAPII cDNA library. Several clones have been isolated, the largest one, HGM-1 encoded 850 amino acid residues (50) . A second screening of the human gastric cDNA library with the previously identified MUC5AC sequences (51) and a RACE-PCR procedure (52) better characterized the fulllength sequence of the 5'-terminus region of MUC5AC. The region, 1,858 amino acid residues long, is composed of the D1, D2, D', and D3 domain in a way comparable to MUC2 and MUC5B. The size of MUC5AC cDNA is estimated to be about 16.6 kb long, therefore encoding a 5525 amino acid long peptide.
Recently, the central domain of MUC5AC has been characterized (53) . It presents a structural organization similar to those of MUC5B. It is composed of 17 major domains. Nine code for cysteine-rich domains (Cys1 to Cys9) and exhibit high sequence similarity to the cysteinerich domains described in the central region of MUC2 and MUC5B. Domains Cys1 to Cys5 are interspersed by domains enriched with serine, threonine and proline residues. Domains Cys5 to Cys9 are interspersed by four domains (TR1 to TR4) composed of various numbers of MUC5AC-type repeats.
Much less information is available regarding MUC5AC promotor. To date, only the computer analysis of its AUG upstream sequence is known. The upstream sequence contains a TATA box located between bases -23 and -29, as well as a nuclear factor -kapaB, Sp1, GRE, AP-2, and a CACCC box (52) . MUC5AC has been shown to be up-regulated by Pseudomonas aeruginosa, with a 15 to 20-fold induction of transcription activity in epithelial cells stably transfected with MUC5AC-luciferase reporter constructs and exposed to Pseudomonas aeruginosa. Several responsive elements for Pseudomonas aeruginosa have been identified in the 4 kb DNA fragment immediately upstream of the MUC5AC transcription site. Li et al. (54) showed that P. aeruginosa lipopolysaccharide activated the SRC-ras-MEK-pp90rsk signaling pathway that leads to the activation of NF-kappaB.
MUC6
Of the four mucins genes clustered on chromosome 11p15, MUC6 is the least characterized (Figure 1 ). The first cDNA clone of MUC6 was originally isolated from a human gastric cDNA library (16) The cDNA sequence is characterized by a tandem repeat region whose individual repeat unit is 507 base pairs (169 amino acids) long. A combination of genomic, cDNA, and PCR techniques was used to isolate the carboxyl-terminal end of MUC6 (55) . The 3'-unique sequence contained 1083 base pairs of coding sequence (361 amino acids) followed by 632 base pairs of the 3'-untranslated region. The coding sequence consists of two distinct regions; the first is 270 amino acids long (62% serine, threonine, and proline with no cysteine residues), and the second containing the carboxy-terminal 91 amino acids (with 12% Cysteine). This domain has approximately 25% amino acid similarity to the CK domain of the human mucins MUC2, 5AC, and 5B and the von Willebrand factor.
Mucus network
Not only is the general structural organization of the gel forming mucins similar to those of the von Willebrand factor, both types of proteins share common properties, such as the formation of inter-molecular disulfide bridges. Indeed, the hemostatic functions of the human von Willebrand factor depend on the normal assembly of disulfide-linked multimers from approximately 250 kDa subunits. Subunits initially form dimers through disulfide bonds of their CK domains. Dimers then form multimers through disulfide bonds of their D domains at the N-terminus of each subunit (56, 57) . In a similar way, mucin monomers form dimers with their CK domains and then, with the D domains from their N-terminal part, form multimers responsible for the tri-dimensional mucus network (58, 59) . The events of disulfide-linked dimerization and the N-glycosylation of the mucin monomers are achieved in the rough reticulum endoplasmic (rER), before the O-glycosylation and the sulfation. Each of the precursors of MUC2, MUC5AC, MUC5B, and MUC6 form a single species of disulfide-linked homo-dimers (59).
Some animal mucins, like the porcine submaxillary mucin (PSM) (60) (61) (62) , the bovine submaxillary mucins (BSM) 1 and 2 (63) (64) (65) , and the frog integumentary mucins (FIM-B.1) (66, 67) , also possess in their distal parts the D (D1, D2, D', D3, and D4), C, and CK domains. In a similar way, the animal mucins form homo-dimer and then multimerize via these domains (58, (68) (69) (70) .
MUC2, MUC5AC, and MUC5B possess in their central domain several domains rich in cysteine amino acid residues, the Cys domains. The numbers of the Cys domains differ from one mucin to another. The Cys domain could be implicated in inter-molecular disulfide formation. As the composition of gel forming mucin differs from tissue to tissue, according to the mucins present, the rheologic properties of the mucus could also be different and specific. This hypothesis has not been corroborated and further investigations are needed.
Soluble mucin, MUC7 3.2.1. Genomic organization
Screening a human submandibular gland cDNA library with a rabbit antibody, anti apo-MG2, isolated the first cDNA clone of MUC7 (71) . MG2 is a low-molecularmass mucin population (150 to 200 kDa) secreted by the submandibular gland and the sublingual salivary glands (72) . The full-length cDNA was isolated and characterized after screening the same library with the previous probe (73) . Compared to the other human mucins, MUC7 has a very simple architectural organization ( Figure 2 ) (a gene of 10 kb long and only 3 exons). The cDNA sequence of MUC7 encodes a 39 kDa protein of 377 amino acid residues. MUC7 reveals five distinct domains (74) . The central domain of the protein is constituted of five or six (depending on the allele) perfect tandem repeats, each comprising 23 residues. A histatin-like domain with a leucine-zipper segment, followed by a moderately glycosylated domain, constitute the N-terminus part, a heavily glycosylated domain, and a second leucine-zipper segment for the C-terminus extremity. The distal regions of MUC7 do not exhibit any cysteine rich domain, only two cysteine residues are present toward its N-terminus part.
Little information is available regarding the regulatory sequences of MUC7. A TATAA box is present at -24 to -19 and a CAAT sequence at -83 to -79 (2) . Several other regulatory elements have also been found including the AP-1 element, the GRE, and the cAMP reponse element.
Antimicrobial agent
Although MUC7 is a low molecular weight mucin with a simple structure, it has a very important function as an antimicrobial agent in the oral cavity. Previous studies have reported that MUC7 in salivary secretions could interact with a variety of microorganisms, such as oral Streptococci (75-77) Pseudomonas aeruginosa, and Staphylococcus aureus (78), Actinobacillus actinomycetemcomitans (79) , and Eikenella corrodens (80) . It has also been reported to agglutinate the AIDS virus HIV-1 (81, 82) and to inhibit HIV infection (83). The two cysteine residues located in the N-terminal region of MUC7 seem to be directly implicated in these activities (77) . Moreover, MUC7 has an anti-candidal activity (84) via its histatin-like domain. The histatins are a family of small histidine-rich peptides found in parotid and submandibular secretions (85) (86) (87) , and the candidacidal properties of these are well known (88,89).
Membrane-bound mucins
The membrane-bound or membrane-associated mucins family is composed of MUC1 (19,90), MUC3 (MUC3A and MUC3B) (14, 91) , MUC4 (3, 92) , and MUC12 (23) . Until recently, MUC1 was the only identified (19,90,93) member of this group and is considered as a mucin-like molecule. At least three members of the subfamily are clustered on chromosome 7 in the region of q22 (14, 23, 91) . They seem to share a common evolutionary history and may come from a common ancestor gene.
The membrane-associated mucins share several properties, as to be expressed by distinct cellular types, epithelial or not. They can be expressed in four distinct forms; membrane-anchored, soluble (proteolytic cleavage of the membrane-bound form), secreted (alternative splicing variants), and lacking the main feature that characterize all mucins, the tandem repeat array (alternative splicing variants) (94) (95) (96) (97) .
For MUC1 and the rat Muc4, the biosynthesis has been shown to follow a specific and uncommon course. Indeed, they reach the apical cell surface in an incompletely glycosylated state and additional oligosaccharides are added to the glycoproteins in a second process involving recycling (98, 99) . The function of this biosynthetic process is still unknown. It has been proposed that in each form, the membrane-associated mucins may play distinct roles.
MUC1
MUC1 is known by several names, the most common being PEM (Polymorphic Epithelial Mucin), episialin, DUPAN-2, DF3, HMFG (human milk fat globule), EMA (epithelial membrane antigen), CD227, and MUC1 (100). It has been isolated from various tissue samples including human mammary epithelial cells (90, 93) , ovarian cells (101) , and pancreatic cells (19) . Although in all these tissues, MUC1 apomucin appears to be identical, each tissue expresses distinct glycoforms with a molecular weight varying from 250 to 500 kDa in the mammary glands (102) or up to 1000 kDa in the pancreas (103) .
Like the other mucins, MUC1 is organized structurally in domains (Figure 3) , with a central domain made up of a sequence repeated in tandem with a perfect unit of repetition of 20 amino acid residues (104) . This domain presents a VNTR polymorphism, varying in size from 400 to 2400 residues. The sequences located on both sides of the central domain are composed of the same unit of repetition with an imperfection that increases with the distance to the center of the protein. The N-terminal extremity is composed of the leader sequence. The deduced amino acids of the remaining part code for three domains: a unique extracellular sequence, a transmembrane sequence, and a cytoplasmic tail. The cDNA consists of seven exons; exon 1 encodes the leader peptide, exon 2 the central domain, and exons 6 and 7 respectively the transmembrane sequence and the cytoplasmic tail. moiety, MUC1 presents a large extended conformation (105, 106) . The negative charges carried by the glycan moiety extend the protein to a size that is predicted to be around 500 nm for its largest allele (106) . This conformation provides anti-adhesive properties to MUC1 (107), properties directly implicated in the morphogenesis of the epithelial tissues (108, 109) , as well as in tumor progression or metastasis by disturbing the cell-cell and/or cell-matrix interactions. However, perturbations of its glycosylation relevant to numerous pathologic situations (110) create new glycosidic epitopes (sialyl Lewisx and sialyl Lewisa), ligands for the P-and E-selectins (111), and ICAM-1 (112) . In this case, MUC1 presents adhesive properties.
Anchored in the membrane with its full O-glycan
MUC1 interacts directly with the beta-catenin via the SXXXXXSSL motif in its cytoplasmic tail (113) . The beta-catenin is a protein that has important functions in the formation of the junction cell-cell by interaction with the Ecadherin (114, 115) . The beta-catenin also binds APC (adenomatous polyposis coli) (114) (115) (116) . APC is an essential partner in the signal pathway Wingless/Wnt-1 (117) . This intracellular pathway is directly implicated in the development of the brain and the axis specification (118) . The activation of this pathway (Wnt-1 expression) results in the accumulation of beta-catenin free in the cytoplasm via an inhibition of the GSK3beta (119, 120) . Whatever the partner that binds the beta-catenin, the complexes are mutually exclusive (121). APC overexpression reduces the level of free cytoplasmic betacatenin, and thus reduces the complexes beta-catenin/Ecadherin along with reducing the intercellular adherence (122, 123) . The formation of these complexes is regulated by the phosphorylation of the cytoplamic tail of each partner by the GSK3beta (124) . After phosphorylation, the beta-catenin is degraded. The GSK3beta is also able to phosphorylate the beta-catenin binding site on the MUC1 cytoplasmic tail (125) . The more the cytoplasmic tail of MUC1 is phosphorylated, the less MUC1 interacts with the beta-catenin (126) . The relative levels of MUC1, Ecadherin, beta-catenin, GSK3beta, and APC seem to be very critical to maintaining the epithelium integrity.
However, when the cytoplasmic tail of MUC1 is glycosylated, it is able to interact with other partners like MUC1/SEC and MUC1/Y (127,128). MUC1/SEC (97, 129) and MUC1/Y are alternative splice variants of the MUC1 gene (130) . MUC1/SEC is an isoform of MUC1, resulting from an alternative splicing event occurring in the 3'-extremity of the tandem repeat array. MUC1/SEC is colinear with the gene. It encodes an open reading frame containing only 160 amino acid residues downstream from the tandem repeat array (97) . MUC1/SEC does not possess the transmembrane sequence and the cytoplasmic tail of MUC1. MUC1 and MUC1/SEC do possess 149 amino acid residues in common in their C-terminal extremity, although, MUC1/SEC has a unique sequence of 11 residues that has been used to generate specific monoclonal antibodies (131). With these antibodies, the existence of the MUC1/SEC protein as a secreted form has been shown by breast cancer cells as well as by body fluids obtained from breast cancer patients (131). MUC1/Y is also an alternative splice variant from the MUC1 gene, with a 1.2 kb full-length cDNA. It is characterized by the deletion of the central domain (encoded completely by exon 2), corresponding to the highly O-glycosylated repetitive sequence (130) . Using a specific antibody (6E6/2), MUC1/Y showed expression in various epithelial tumors, such as breast and ovarian cancers, but it is undetectable in the adjacent normal tissue (132, 133) . MUC1/Y seems to act as a membrane receptor that undergoes tyrosine and serine phosphorylation and to activate the signaling cascade via GRB2 (128) MUC1 is an O-glycoprotein that is expressed at a basal level in most epithelial cells (135) . Computer analysis of the 5'-sequence upstream of the initiation point reveals the presence of 104 Cys elements in the sense strand and 67 in the antisense (33, 35, 136, 137) . Ubiquitous Cys elements are found, such as TATA box, CCAAT-, E-, and GCboxes. Other elements found are boxes that bind AP1, AP2, AP3, AP4, CTF/NF1, ER, PR, Sp1, STAT1, STAT3, STAT5, and YY1. Different boxes for tissue-specific regulation are also found including elements regulating the transcription in mammary epithelial cells (MAF, MGF, MP4, RME, PMR, SpA, and WAP), elements specific for transcription in hemapoetic cells (BKLF/TEFII, GATA1, vMyb, c-Myb, and MZF1), elements responsible for the transcription in immunospecific cells (AML-1, Gfi-1, Ikaros, IL-6 RE, LyF1, NF-GMCSF, NF-mu-E1, NF-Y, Pu-box, SRY, TCF-1, TdT Inr, XBP1, and W-element), the elements that are responsible for the transcription in hepatocytes (ARP-1, HNF-5, LF-A1, and H-APF1), elements that control the transcription in muscle cells (Myo D, Nkx-2.5, and SEF1), and elements specific for viral promoters ( JCV, LBP-1, LVC, PEA1, PEA3, PV-E2, T-ag SV40, retroviral TATA-box, TEF-1, TEF-2, and TFII-MLInr2) (138) . Interestingly, a large proportion of these cys elements are clustered or have overlapping sequences that suggest a very precise mechanism of regulation. Moreover, the 5' and 3' regions of the MUC1 promoter possess independent promoter activities. The TATA box and the GC boxes located at -30/-25 and -90/-137, respectively, could govern formation of the initiation complex (ITC), in the 3'-end regulated transcription, while two initiator elements, TFII-1-ML-Inr2 (-661/-653) and TdT Inr (-634/-627), might control the ITC formation in the 5'-end regulated transcription (137) . These different ITCs could be involved in the transcription of specific MUC1 isoforms.
Cluster of mucins located in 7q22 3.3.2.1. MUC3
The sequences of MUC3, A and B, are partially known (Figure 3 ). MUC3 was initially reported after the screening of a small intestinal lambda gt11 cDNA library using antibodies raised against deglycosylated small intestinal mucins (14) . Two partial cDNA clones, SIB124 and SIB139, were isolated and sequenced. They encoded 17 amino acid residues repeated in tandem. With the use of this sequence as a probe, two other coding sequences repeated in tandem have also been described for MUC3; one of 1125 bp (139) , and one of 177 bp (140) . The organization of the central repetitive domain of MUC3 remains unclear. It presents a VNTR polymorphism with a 51 bp repetitive sequence (139) . MUC3 has been located on chromosome 7 in the region q22. The smallest fragment recognized by the 51 bp tandem repeat has a size of 200 kb (139) . MUC3 appears to be a huge gene.
RT-PCR and cDNA library screening procedures have been used to characterize the 3'-terminus region of MUC3. It appears that the MUC3 gene, by an alternative splicing mechanism, encodes a family of proteins that can be membrane-bound or secreted (96, 141) . To date, four distinct splice variants have been described for MUC3. One has a 3'-terminus extremity composed of 10 exons that code for the membrane bound form of MUC3 (141) . The exon 2 and 7 code for two EGF-like domains, exon 8 codes for the transmembrane domain and the exons 9, 10, and 11 code for the cytoplasmic tail. The three other splice variants code for the secreted forms of MUC3, in which distinct domains, such as the second EGF-like domain, are deleted (96,141).
The 5'-extremity of the central domain of MUC3 as well as the 5'-terminal sequences is still unknown. The organization of the central domain, which appears to be complex, might explain why the sequence of MUC3 is still uncompleted. Its rat homologue (142) as well as its mouse homologue (143) have been identified but also in these cases, only a partial sequence of the central domain and 3'-terminal extremity are known. With their human homologue, they code for a membrane-bound mucin that contains two EGF-like domains. No splice variant has been described.
Recently, based on nucleotide changes observed in its sequence from one single individual, the existence of a second MUC3 gene carried by the same 200 kb DNA fragment has been proposed (91) . Both MUC3 genes, now called MUC3A and MUC3B, show a unique exonic sequence ranging from 94 to 100% identity and 95% similarity for the intronic sequences. To date, nothing is known about the functions of MUC3 (A and B).
MUC12
MUC12 is a recently described mucin. The first cDNA fragment of MUC12, dd29, has been identified using a differential display procedure using colorectal cancer and normal colon samples (23) . The dd29 clone encodes a 28-amino acid residue degenerated tandem repeat that presents 71% similarity with that of MUC11. Using cDNA library screening and RT-PCR techniques, the 3'-terminus of MUC12 has been characterized. It presents the same structure as MUC3, with two EGF-like domains, one transmembrane sequence, and a cytoplasmic tail. MUC12 and MUC3 C-termini present 34% and 38% homology, respectively, with the rodent protein known as rMuc3. The three molecules also share the same domain organization distinct from that of MUC4 (Figure 3 ). It is difficult to actually describe rMuc3 as the rodent homologue of MUC3 or MUC12. Even if MUC12 seems to be closely related to MUC3, it presents a distinct pattern of expression (23) .
The recent descriptions of MUC12 as well as the putative existence of two MUC3 (MUC3A and MUC3B) open the field of investigation for the comprehension of the functions of the membrane-bound mucins.
MUC4
MUC4 was initially identified after the screening of a lambda gt11 cDNA library constructed from human tracheo-bronchial mucosa with a polyclonal antiserum raised against deglycosylated glycopeptides from human bronchial mucins (15) . One cDNA fragment has been isolated and named JER64. It contains 48 bp tandem repeat sequence. The corresponding gene has been localized with JER64 used as a probe on the chromosome 3 in the region q29 (4, 15) . Using this probe, MUC4 has been shown to exhibit a VNTR polymorphism in its tandem repeat array. Alleles observed vary between 7 and 19 kb after digestion by EcoRI/PstI endonuclease and correspond to a variation in the number of repetitions ranging from 145 to 395 units (3, 4) . By RT-PCR RACE-PCR experiments and cDNA library screening, the full-length sequence of MUC4 has been characterized ( Figure 3) (3,92) . Its deduced amino acid sequence consists of a 27-residue peptide signal followed by three imperfect repetitions of a motif varying from 126 to 130 residues and by a unique sequence of 554 residues. The central domain is composed of a perfect repetition of 16 residues. The C-terminal region can be divided into 12 domains (CT1 to CT12). It possesses two domains rich in N-glycosylation sites, three EGF-like domains, a transmembrane sequence and, a cytoplasmic tail (3, 92, 144) . A GDPH cleavage site is found between the domains CT4 and CT5. The MUC4 precursor, a 930 kDa apomucin, provides the MUC4alpha and MUC4beta subunits. MUC4 is predicted to be a membrane-associated 2.12 mm long mucin, in which MUC4alpha is the mucin type-associated subunit and MUC4beta is the growth factor-like subunit.
To date, 24 distinct cDNAs, transcript from MUC4 gene, have been identified (94, 95, 144) . They result from a complex alternative splicing mechanism, mainly of the 3'-terminal region, but also for two of them, by an alternative splicing of the central repetitive domain. No precise functions have been attributed to MUC4 products, but some functions are known for the rat homologue of MUC4, rMuc4, or SMC (sialo mucin complex) (92, 145, 146) . Even if the rMuc4 shares the same structural organization as MUC4, no splice variants have yet been characterized. rMuc4 is characterized under two distinct forms, a membrane-bound and a soluble form. The soluble form results from the proteolityc cleavage of the membrane-associated form (147) . As is the case for MUC1, anchored in the membrane with its full O-glycan moiety, rMuc4 presents a large extended conformation that provides anti-adhesive properties (148, 149) . These properties are implicated in the cell-matrix and cell-cell interactions, in tumor progression or metastasis (150) , as well as in protection again the natural killer cells (151) . rMuc4 also appears to be able to interact with the protooncogene ErbB2 (152) , but the effect of this interaction is unclear.
Uunclassified mucins
The unclassified mucins are partially known mucins for which only a short cDNA sequence of the repetitive sequence has been characterized.
MUC8
Polyclonal antibodies against deglycosylated human tracheo-bronchial mucin were used to select immunoreactive clones from a Uni-ZAP cDNA expression library prepared from normal human tracheal mRNA (153) . One positive clone, designated pAM1, revealed a partial 941 bp cDNA that encoded a 313-amino acid polypeptide. It consisted of imperfect 41-nucleotide tandem repeats that encoded a unique polypeptide with two types of consensus repeats. The corresponding gene was mapped to chromosome 12 in the region q24.3. Using the RACE-PCR procedure, the 3'-terminus region has been cloned (22) . It contains only a very short coding unique sequence followed by a stop codon and a 458 bp of 3'-untranslated region. Due to the lack of longer carboxy coding sequence, MUC8 is still considered an unclassified mucin.
MUC11
Like MUC12, the first cDNA fragment of MUC11, called dd34, has been identified using a differential display procedure of colorectal cancer and normal colon tissue samples (23) . This cDNA fragment is the only sequence known to date for MUC11. It is 2.8 kb long and encodes a degenerated sequence repeat in tandem of 28 amino acid residues. The repetitive sequence of MUC11 shares 71% similarity with that of MUC12. Because of its localization, chromosome 7 in q22, MUC11, like MUC12, MUC3A, and MUC3B may encode a membrane-bound mucin.
PERSPECTIVES
This article presents for the first time a complete review of current knowledge of structural organization of all discovered human mucin genes.
Mucin, or not mucin, that is the question?
New molecules, discovered all along the years, share with mucins some structural properties, like secreted by epithelial cells, possess a mucin-like domain (name given to a domain rich in serine, threonine and proline amino acid residues), and an EGF-repeat growth-factor like subdomain. Even if these molecules do not possess the classical mucin structure, some of them received a MUC designation, for instance, the recently discovered MUC13 (154) . MUC13 is a low molecular weight membrane-bound protein (54 kDa) that possesses a mucin like small domain (two repetitions rich in serine, threonine, and proline residues) and three EGF-like domains. Because of its structural organization, MUC13 can be defined as a "minimucin". It is possible that the growth factor functions of MUC13, devoid of mucin repeat, are more important than the classical mucin functions. It has maintained the tandem repeat domain for its simpler expression. MUC13 appears to be a mucin for which the growth factor functions are more important than the mucin functions and so have raised the evolution of the molecule.
In summary, mucins appear to be a complex family with three distinct structures (gel-forming, soluble, and membrane-bound,) and so potentially three distinct patterns of functions. Historically, mucins were defined as the main component of the mucus, with the function of protecting and lubricating all epithelium. Mucins were considered to be the first immunological system. Recent developments regarding the relation structure-function of the mucins carry implications for the mucins. They may be directly implicated in the development as well as in the integrity of the epitheliums. Dysregulation of their expression seems to play a key role in tumoral and metastatic progression. Now that the structure of the mucin genes are being known, research can be directed toward the comprehension of these complex mechanisms. 
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